bis-benzimidazole has been researched along with Staphylococcal Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dale, AG; Hinds, J; Mann, J; Neidle, S; Taylor, PW | 1 |
1 other study(ies) available for bis-benzimidazole and Staphylococcal Infections
| Article | Year |
|---|---|
Symmetric bis-benzimidazoles are potent anti-staphylococcal agents with dual inhibitory mechanisms against DNA gyrase.
Topics: Anti-Bacterial Agents; Benzimidazoles; DNA Breaks, Single-Stranded; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Topoisomerase II Inhibitors | 2012 |